PLUS Therapeutics director exercises 922 RSUs
PLUS THERAPEUTICS director Ronald Asbury Andrews exercised equity awards, acquiring additional common stock through RSU vesting.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
PLUS THERAPEUTICS director Ronald Asbury Andrews exercised equity awards, acquiring additional common stock through RSU vesting. On July 1, 2026, 922 Restricted Stock Units converted into 922 shares of common stock at a stated price of $0.00 per share as part of his compensation. Following the transaction, he directly holds 922 shares of common stock and 2,764 Restricted Stock Units that represent rights to receive the same number of shares, vesting in four substantially equal quarterly installments beginning on July 1, 2026.
Insider Trade Summary
922 shares exercised/converted
Exercise
2 txns
Insider
ANDREWS RONALD ASBURY
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 922 | $0.00 | $0.00 |
| Exercise | Common Stock | 922 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units — 2,764 contracts (Direct);
Common Stock — 922 shares (Direct)
Footnotes (2)
- F1. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the issuer's Common Stock.
- F2. Represents the vesting of an RSU grant which occurs in four substantially equal quarterly installments beginning on July 1, 2026.
Key Figures
Common shares acquired: 922 shares
Common shares held after: 922 shares
RSUs held after: 2,764 units
+3 more
6 metrics
Common shares acquired
922 shares
Converted from RSUs on July 1, 2026
Common shares held after
922 shares
Direct ownership following the transaction
RSUs held after
2,764 units
Restricted Stock Units outstanding after conversion
RSUs converted
922 units
RSUs converted into common stock on July 1, 2026
Stated conversion price
$0.00 per share
Price per share for RSU conversion
Vesting structure
Four quarterly installments
Beginning on July 1, 2026 for the RSU grant
Key Terms
Restricted Stock Units, RSU, derivative security, exercise or conversion, +1 more
5 terms
Restricted Stock Units financial
"Represents the vesting of an RSU grant which occurs in four substantially equal quarterly installments"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
RSU financial
"Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share"
Restricted stock units (RSUs) are a form of company shares given to employees as part of their compensation, usually with certain restrictions or conditions, such as remaining with the company for a set period. When these restrictions lift, employees receive actual shares that they can sell or hold. For investors, RSUs can impact a company's stock supply and reflect the company's commitment to attracting and retaining talent.
derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
exercise or conversion financial
"transaction_action": "derivative exercise/conversion""
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did PLUS THERAPEUTICS (PSTV) report for Ronald Asbury Andrews?
PLUS THERAPEUTICS reported that director Ronald Asbury Andrews acquired 922 shares of common stock on July 1, 2026. The shares came from the vesting and conversion of 922 Restricted Stock Units, a routine equity compensation event rather than an open-market stock purchase or sale.
What are the remaining Restricted Stock Units reported for Ronald Asbury Andrews at PLUS THERAPEUTICS (PSTV)?
After the reported transaction, Ronald Asbury Andrews held 2,764 Restricted Stock Units. Each RSU represents a contingent right to receive one share of PLUS THERAPEUTICS common stock, providing additional potential future share ownership as these units continue to vest over time.
How do the PLUS THERAPEUTICS (PSTV) RSUs for Ronald Asbury Andrews vest over time?
Ronald Asbury Andrews’ Restricted Stock Units vest in four substantially equal quarterly installments beginning on July 1, 2026. This schedule spreads the equity compensation over one year, with each vesting date converting a portion of RSUs into common shares at the stated terms.
Was there any open-market buying or selling in the PLUS THERAPEUTICS (PSTV) Form 4 for Ronald Asbury Andrews?
The Form 4 for Ronald Asbury Andrews shows no open-market buying or selling activity. It reports an M-code transaction classified as an exercise or conversion of derivative securities, in which Restricted Stock Units converted into common stock as part of his equity compensation.
What does the M transaction code mean in the PLUS THERAPEUTICS (PSTV) Form 4 for Ronald Asbury Andrews?
The M transaction code in this Form 4 indicates an exercise or conversion of a derivative security. For Ronald Asbury Andrews, it reflects Restricted Stock Units converting into 922 shares of PLUS THERAPEUTICS common stock rather than a direct purchase or sale on the open market.
AI-generated analysis. How Rhea-AI works. Not financial advice.
